Information On Actos Litigation
In order to combat the health problems associated with Type 2 diabetes, many consumers have turned to the prescription drug Actos. Actos is prescribed to adults that need help controlling their blood sugar and was advertised as a way to help the body make use of its natural insulin and slow sugar production in the liver.
According to an on-going 10 year study that is currently halfway through its development, using Actos for more than one year increases the chance of developing bladder cancer by 40% and leaves 10 people in every 10,000 subject to this disease. This study was conducted by the manufacturer of Actos, Takeda Pharmaceuticals. The study asserts that a significant risk of bladder cancer only increases in patients who have taken large amounts of the drug or who have taken the drug long term, but that there is no significant increase for Actos users overall. However, a separate study conducted in France influenced the government there to suspend use of the drug, and Germany has advised against prescribing the drug to any new patients. In addition, a study conducted on data between the years 2004 and 2009 has determined that a full 20% of all Type 2 diabetes patients suffering from bladder cancer have been prescribed Actos at some point.
Actos and the FDA
In June of 2011, the United States Food and Drug Administration finally released a safety announcement to the public regarding a possible link between the active ingredient in Actos, pioglitazone, and the development of bladder cancer. The information states that anyone who uses Actos for more than one year may be at an increased risk of developing bladder cancer and that a new warning would be added to the Actos label. In addition to this warning, the new label warns those who have active bladder cancer to avoid using Actos to treat their Type 2 diabetes.
Bladder Cancer Signs and Treatment Options
Some of the most common signs of bladder cancer include painful urination, frequent urination, pain in the back or abdomen, blood in the urine, and frequent urinary tract infections. Treatment for bladder cancer involves removing cancerous tumors without affecting the rest of the bladder if it is caught in the early stage of development. However, bladder cancer frequently requires a radical cystectomy if it has advanced into later stages. This surgery includes the removal of the bladder and the surrounding organs such as the uterus, ovaries, fallopian tubes, cervix, front wall of the vagina, and the urethra.
Sadly, even after these extreme measures, patients only have around a 50% chance of avoiding bladder cancer in the future. Radiation and chemotherapy have been used in conjunction with radical cystectomy, however, they have not been documented to increase survival significantly.
Taking Legal Action
Unfortunately, pharmaceutical defects are a reality and many people who have taken a prescription drug in order to treat one illness have ended up suffering from something far worse. If you have taken Actos and developed bladder cancer, you may consider consulting an attorney about your legal options. As with Granuflo litigation, filing an Actos lawsuit can provide you with what you need about pursuing compensation for the damage done by an unsafe prescription medication.